According to a report in Research Nester, by 2021, the market for stem cell regenerative medicine will reach over 50 Billion USD with European countries surpassing North America by 2019. Furthermore, Asia-Pacific countries are becoming the front-runners in regenerative medicine product suppliers, therefore increasing their market as well in the field. The surge in stem cell research means more advancement in alternatives to traditional, more invasive medical procedures and a better overall medical industry. At Orthohealing we research the best practices around the globe to provide our patients with the most current & advanced regenerative care available. It’s exciting to see the growth in the field emerge.
